Top Industry Leaders in the Wolff Parkinson White Syndrome Market
Latestย Wolff Parkinson White syndromeย Companiesย Updates:
Abbott (US): Announced FDA approval for its new Carto 3โข System with Surround Sound technology in July 2023, potentially offering improved mapping and navigation capabilities during ablation procedures, which are sometimes used to treat WPW.
Boston Scientific (US): Received CE Mark approval for its TactiCathยฎ Contact Force Sensing Catheter in September 2023, which may enhance safety and efficacy of catheter ablation procedures, including those for WPW.
Biosense Webster (US): Highlighted its CARTOSยฎ System's role in complex cardiac ablation procedures, including WPW, in its recent clinical study presentations.
CardioNet (US): Launched its new Remote Patient Monitoring (RPM) platform for patients with arrhythmias, including those with WPW, in October 2023, enabling continuous monitoring and early detection of potential complications.
Philips (Netherlands): Showcased its advanced ECG devices and AI-powered analysis tools for accurate diagnosis of arrhythmias, including WPW, at its recent medical conference participation.
List ofย Wolff Parkinson White Syndromeย Key companies in the market:
- AngioDynamics
- Medtronic
- Boston Scientific Corporation
- St. Jude Medical, LLC
- Abbott
- GlaxoSmithKline LLC
- Teva Pharmaceutical Industries
- Sanofi S.A.
- Novartis International AG